Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabete
The Wegovy injection is FDA-approved for weight loss in adults and children aged 12 and older with obesity and adults with overweight and at least one weight-related medical condition
Increased function of inhibitory neuronal M2 muscarinic receptors in trachea and ileum of diabetic rats
"Offering Zepbound single-dose vialsthe most affordable branded incretin medicine by list pricethrough another platform to LillyDirect will help ensure broader availability of rigorously tested, FDA-approved and regulated obesity treatment," said Patrik Jonsson, executive vice president, and president of Lilly Cardiometabolic Health and Lilly USA in a statement
